<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">Colorectal tumors</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) with microsatellite instability (MSI) show resistance to chemotherapy with <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5-FU), the most widely used pharmacological drug for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> treatment </plain></SENT>
<SENT sid="1" pm="."><plain>The aims of this study were to test the ability of <z:chebi fb="0" ids="16243">quercetin</z:chebi> (Q) and <z:chebi fb="0" ids="15864">luteolin</z:chebi> (L) to increase the sensitivity of MSI <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells to 5-FU and characterize the dependence of the effects on cells' p53 status </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Two MSI human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>-derived cell lines were used: CO115 <z:mp ids='MP_0002169'>wild type</z:mp> (wt) for p53 and HCT15 that harbors a p53 mutation </plain></SENT>
<SENT sid="3" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> induction in these cells by 5-FU, Q and L alone, and in combinations was evaluated by TUNEL and western blot </plain></SENT>
<SENT sid="4" pm="."><plain>The dependence of the effects on p53 was confirmed by small interference <z:chebi fb="40" ids="33697">RNA</z:chebi> (siRNA) in CO115 cells and in MSI HCT116 wt and p53 knockout cells </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: CO115 p53-wt cells are more sensitive to 5-FU than the p53-mutated HCT15 </plain></SENT>
<SENT sid="6" pm="."><plain>The combination treatment of 5-FU with L and Q <z:mp ids='MP_0006042'>increased apoptosis</z:mp> with a significant effect for Q in CO115 </plain></SENT>
<SENT sid="7" pm="."><plain>Both <z:chebi fb="5" ids="47916">flavonoids</z:chebi> increased p53 expression in both cell lines, an effect particularly remarkable for Q </plain></SENT>
<SENT sid="8" pm="."><plain>The significant apoptotic enhancement in CO115 incubated with Q plus 5-FU involved the activation of the apoptotic <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> pathway </plain></SENT>
<SENT sid="9" pm="."><plain>Importantly, knockdown of p53 by siRNA in CO115 cells and p53 knockout in HCT116 cells totally abrogated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induction, demonstrating the dependence of the effect on p53 modulation by Q </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: This study suggests the potential applicability of these phytochemicals for enhancement 5-FU efficiency in MSI <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> therapy, especially Q in p53 wt <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>